InvestorsObserver
×
News Home

Will Meridian Bioscience Inc (VIVO) Outperform the Rest of the Stocks in the Healthcare Sector?

Monday, January 23, 2023 03:18 PM | InvestorsObserver Analysts

Mentioned in this article

Will Meridian Bioscience Inc (VIVO) Outperform the Rest of the Stocks in the Healthcare Sector?

A rating of 86 puts Meridian Bioscience Inc (VIVO) near the top of the Healthcare sector according to InvestorsObserver. Meridian Bioscience Inc's score of 86 means that it ranks higher than 86% of stocks in the sector. In addition, its overall score of 94 ranks it higher than 94% of all stocks.

Overall Score - 94
VIVO has an Overall Score of 94. Find out what this means to you and get the rest of the rankings on VIVO!

What do These Ratings Mean?

Searching for the best stocks to invest in can be difficult. There are thousands of options and it can be confusing on what actually constitutes a great value. *Investors Observer* allows you to choose from eight unique metrics to view the top industries and the best performing stocks in that industry. A score of 94 would rank higher than 94 percent of all stocks. Our proprietary scoring system captures technical factors, fundamental analysis and the opinions of analysts on Wall Street. This makes InvestorsObserver’s overall rating a great way to get started, regardless of your investing style. Percentile-ranked scores are also easy to understand. A score of 100 is the top and a 0 is the bottom. There’s no need to try to remember what is “good” for a bunch of complicated ratios, just pay attention to which numbers are the highest.

What's Happening With Meridian Bioscience Inc Stock Today?

Meridian Bioscience Inc (VIVO) stock is trading at $33.84 as of 3:17 PM on Monday, Jan 23, an increase of $0.10, or 0.3% from the previous closing price of $33.74. Volume today is light. So far 386,079 shares have traded compared to average volume of 649,466 shares. The stock has traded between $33.69 and $33.89 so far today. Click Here to get the full Stock Report for Meridian Bioscience Inc stock.

You May Also Like

Get the InvestorsObserver App

InvestorsObserver App
iOS App Android App